Revolo Biotherapeutics

“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office

“We’ve seen some tremendous acceleration in science over the past few years and that science is the driving force behind new medicines. The fundamental need for these new medicines is the underpinning

With understanding of immune function advancing in leaps and bounds and a continuing proliferation of tools to manipulate it, expectations are high for advances in oncology and immunology over the com

As we enter the third year of the COVID-19 pandemic, the pharma industry has begun to adapt and grow around its constraints and opportunities. After the all-hands-on-deck scramble in early 2020, busin